Loading...
XTAI
3705
Market cap558mUSD
Jul 14, Last price  
61.40TWD
1D
-0.97%
1Q
-4.66%
Jan 2017
34.50%
IPO
48.67%
Name

YungShin Global Holding Corp

Chart & Performance

D1W1MN
P/E
14.00
P/S
2.04
EPS
4.39
Div Yield, %
3.75%
Shrs. gr., 5y
3.05%
Rev. gr., 5y
-0.39%
Revenues
8.03b
+14.29%
2,809,298,0002,962,109,000940,621,0004,079,435,0004,143,011,0004,501,605,0004,702,806,0005,061,661,0005,826,555,0006,034,169,0006,190,862,0006,622,635,0007,513,686,0008,191,531,0008,084,664,0007,805,055,0007,311,769,0007,027,937,0008,031,903,000
Net income
1.17b
+41.24%
722,221,000470,666,000119,604,000524,219,000635,063,000554,130,000444,535,000618,969,000720,058,000893,254,000657,993,000514,056,000701,982,000748,601,000791,720,000736,622,000839,035,000827,304,0001,168,508,000
CFO
1.36b
+14.97%
963,533,000590,064,000128,708,000911,516,000685,209,000356,215,000798,993,0001,193,894,0001,193,596,000556,843,000645,633,000524,555,000953,914,000940,649,0001,227,317,000968,358,000967,245,0001,180,415,0001,357,121,000
Dividend
Jun 24, 20253 TWD/sh

Profile

YungShin Global Holding Corporation, through its subsidiaries, engages in the investment, manufacture, and sale of medicines, animal drugs, agricultural chemicals, industrial medicine, and cosmetics in Taiwan, Mainland China, Japan, and the United States. The company engages in the extraction, manufacture, and sale of wood products; manufacture and sale of over-the-counter drugs, preparations, and chemical intermediates; and pharmaceutical research, transfer, authorization, and outsourcing of services, as well as import and export trading. In addition, it is involved in the trading, wholesale, and retail of health products, cosmetics, medicines, human testing reagents, and the aforesaid related raw materials; semi-finished products; and production equipment. The company was founded in 1952 and is based in Taichung, Taiwan.
URL
http://www.yungshingroup.com/
IPO date
Jan 03, 2011
Employees
Domiciled in
TW
Incorporated in
TW

Valuation

Title
TWD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
8,031,903
14.29%
7,027,937
-3.88%
7,311,769
-6.32%
Cost of revenue
6,741,448
6,097,734
6,553,889
Unusual Expense (Income)
NOPBT
1,290,455
930,203
757,880
NOPBT Margin
16.07%
13.24%
10.37%
Operating Taxes
354,424
266,314
211,689
Tax Rate
27.47%
28.63%
27.93%
NOPAT
936,031
663,889
546,191
Net income
1,168,508
41.24%
827,304
-1.40%
839,035
13.90%
Dividends
(672,883)
(649,933)
(463,704)
Dividend yield
4.03%
5.25%
3.78%
Proceeds from repurchase of equity
(57,922)
BB yield
0.47%
Debt
Debt current
814,009
989,021
1,682,838
Long-term debt
465,813
267,357
175,841
Deferred revenue
407,102
359,482
350,933
Other long-term liabilities
48,548
168,131
275,765
Net debt
(1,802,630)
(1,748,661)
(1,224,293)
Cash flow
Cash from operating activities
1,357,121
1,180,415
967,245
CAPEX
(225,706)
(124,996)
(170,732)
Cash from investing activities
(179,309)
(409,376)
423,029
Cash from financing activities
(846,084)
(1,195,022)
(702,179)
FCF
(656,006)
847,863
1,258,673
Balance
Cash
2,269,623
1,808,054
2,022,030
Long term investments
812,829
1,196,985
1,060,942
Excess cash
2,680,857
2,653,642
2,717,384
Stockholders' equity
6,611,723
5,576,928
5,364,216
Invested Capital
8,981,260
7,028,359
7,299,214
ROIC
11.69%
9.27%
7.08%
ROCE
10.68%
9.23%
7.31%
EV
Common stock shares outstanding
309,665
266,438
266,437
Price
53.90
15.91%
46.50
1.09%
46.00
7.10%
Market cap
16,690,952
34.72%
12,389,367
1.09%
12,256,102
7.10%
EV
16,895,063
11,212,995
11,575,068
EBITDA
1,586,909
1,224,735
1,133,741
EV/EBITDA
10.65
9.16
10.21
Interest
28,526
35,277
32,862
Interest/NOPBT
2.21%
3.79%
4.34%